STOCK TITAN

ACME United (NYSE: ACU) CEO option grant, exercise and share disposal

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ACME United Corp director and CEO Walter C. Johnsen reported multiple equity compensation transactions. On March 2, 2026, he received a grant of 25,000 employee stock options at an exercise price of $44.77 per share. According to a footnote, 6,250 options vest on each of March 2, 2027, 2028, 2029, and 2030.

On February 27, 2026, he exercised 30,000 employee stock options at $21.49 per share and acquired 30,000 shares of common stock through this derivative exercise. The same day, he disposed of 30,000 common shares to the issuer at $45.88 per share. A footnote states this option exercise was settled on a net cash basis directly with the issuer and did not involve the actual issuance of any underlying common shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
JOHNSEN WALTER C

(Last) (First) (Middle)
1 WATERVIEW DRIVE

(Street)
SHELTON CT 06484

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ACME UNITED CORP [ ACU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Chairman and CEO
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/27/2026 02/27/2026 M 30,000 A $21.49 344,999 D
Common Stock 02/27/2026 02/27/2026 D 30,000(1) D $45.88 314,999 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option $21.49 02/27/2026 02/27/2026 M 30,000 08/03/2020 08/03/2026 Common Stock 30,000 $21.49 388,500 D
Employee Stock Option $44.77 03/02/2026 03/02/2026 A 25,000(2) 03/02/2030 03/02/2036 Common Stock 25,000 $44.77 413,500 D
Explanation of Responses:
1. The exercise of the subject option was effected on a net cash settlement basis in a transaction directly with the issuer not involving the actual issuance of any shares of the underlying common stock.
2. 6,250 shares will vest on March 2, 2027. 6,250 shares will vest on March 2, 2028. 6,250 shares will vest on March 2, 2029. 6,250 shares will vest on March 2, 2030.
/s/ Walter C. Johnsen 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did ACU Chairman and CEO Walter C. Johnsen report?

Walter C. Johnsen reported an option grant, an option exercise, and a related share disposition. He received 25,000 employee stock options, exercised 30,000 options into common stock, and disposed of 30,000 common shares back to the issuer in a net cash settlement transaction.

What are the terms of Walter C. Johnsen’s new stock option grant at ACU?

Johnsen received 25,000 employee stock options at an exercise price of $44.77 per share. A footnote explains vesting: 6,250 options vest on March 2 in each of 2027, 2028, 2029, and 2030, creating a four-year vesting schedule.

How many ACU options did Walter C. Johnsen exercise and at what price?

He exercised 30,000 employee stock options on February 27, 2026 at an exercise price of $21.49 per share. This derivative exercise converted options into 30,000 shares of common stock as part of the reported equity compensation activity.

What happened to the 30,000 ACU common shares after the option exercise?

On the same date as the exercise, 30,000 common shares were disposed of to the issuer at $45.88 per share. A footnote states the option exercise used net cash settlement directly with the issuer and did not involve actual issuance of any underlying shares.

How do the vesting dates for ACU CEO Walter C. Johnsen’s new options break down?

The 25,000 new options vest in four equal installments. Footnote disclosure states that 6,250 options will vest on March 2, 2027, another 6,250 on March 2, 2028, 6,250 on March 2, 2029, and the final 6,250 on March 2, 2030.
Acme United Corp

NYSE:ACU

ACU Rankings

ACU Latest News

ACU Latest SEC Filings

ACU Stock Data

165.78M
3.34M
Household & Personal Products
Cutlery, Handtools & General Hardware
Link
United States
SHELTON